AnaptysBio, Inc.
ANAB
$26.58
$0.240.91%
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 171.40% | -4.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 171.40% | -4.10% | |||
| Cost of Revenue | 8.57% | -6.21% | |||
| Gross Profit | 11.03% | 6.46% | |||
| SG&A Expenses | 1.02% | -4.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.70% | -5.86% | |||
| Operating Income | 7.78% | 6.01% | |||
| Income Before Tax | -13.15% | 6.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.14% | 6.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.14% | 6.37% | |||
| EBIT | 7.78% | 6.01% | |||
| EBITDA | 7.83% | 6.02% | |||
| EPS Basic | -12.97% | 6.07% | |||
| Normalized Basic EPS | 6.66% | 6.07% | |||
| EPS Diluted | -12.62% | 6.00% | |||
| Normalized Diluted EPS | 6.66% | 6.07% | |||
| Average Basic Shares Outstanding | 0.15% | -0.31% | |||
| Average Diluted Shares Outstanding | 0.15% | -0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
